None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Voluntary man or women between 18 and 45 years. 2. Photo type III to V. 3. Having apparently healthy skin on test area 4. For whom the investigator considers that the compliance will be correct. 5. Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures. 6. Having signed a Consent Form. 7. Should be able to read and write (in English, Hindi or local language). 8. Having valid proof of identity and age.
Exclusion criteria
Exclusion criteria: 1. Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study. 2. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition. 3. Have open sores or open lesions in the treatment area. 4. Have any condition that in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product. 5. Have participated in any interventional clinical trial in the previous 90 days. 6. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication including corticosteroids. 7. Have not skin related issues.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Presence of Titanium Dioxide 2. Presence of BEMT 3. Presence of DHBTTimepoint: At T+0hrs, T+3hrs, T+6hrs | — |
Secondary
| Measure | Time frame |
|---|---|
| Not ApplicableTimepoint: Not Applicable | — |
Countries
India
Contacts
CCFT Laboratories